Quick Search

 

 


 

 

Home > Result Summaries: Compounds > naratriptan > Result Summary for S2WA1007

Result Summary for S2WA1007

Result Summary
Protocol ID: S2WA1007
Clinical Study ID: S2WA1007
Official Title: A study to evaluate the pharmacokinetics and pharmacodynamics of oral naratriptan in migraine subjects.
Phase: Phase 1
Study Indications or Diseases:
  • Migraine Disorders
Generic Name: naratriptan
Trade/Product Name: amerge;naramig
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Fuseau E: Acute treatment of migraine with oral naratriptan: The concentration-efficacy relationship: CLIN. PHARMACOL. THER. 1998;63(2):187.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.